| FNGR 0.398 129.53% | CHAI 0.4 57.11% | LGCL 0.0389 -27.02% | CYAB 0.4467 45.36% | NVDA 217.55 -4.57% | CHGA 2.852 2,082.10% | PCG 16.6 -7.52% | NCPL 0.6916 28.41% | NVD 4.05 8.58% | BITO 10.45 -3.06% | IREN 35.45 -12.53% | INTC 89.47 -2.85% | NU 14.3 -3.90% | IBIT 43.9 -3.07% | XTNT 0.384 16.36% | TSLL 8.98 -3.54% | ONDS 7.9 -9.71% | DUO 0.9602 37.56% | AAL 13.64 -0.58% | SOAR 0.2169 5.80% | SOXL 111.34 -9.52% | BTAI 0.1814 -74.76% | TQQQ 71.85 -1.98% | ETHA 18.37 -2.65% | FTFT 2.2188 281.50% | SPCX 141.5 0.45% | PATH 18.15 -0.98% | BMNR 23.8 -7.14% | NOK 10.21 -3.59% | AMZN 266.43 3.97% | MRVL 216.62 -10.28% | SOXS 49.82 9.86% | WHLR 1.07 -4.46% | SQQQ 38.54 2.03% | PLUG 2.19 -3.52% | SOFI 18.06 -5.84% | AEMD 2.49 14.75% | SPDN 8.49 0.12% | QID 14.24 1.42% | MARA 10.67 -10.11% | KEEL 3.23 -7.98% | GDX 99.65 -3.90% | RIVN 16.07 -4.35% | F 13.87 -0.57% | BTG 5.66 -2.92% | AAPL 319.7 1.63% | PURR 11.61 -9.51% | SMR 9.29 -4.62% | VALE 15.03 -1.83% | SPY 769.35 -0.23%

Curaleaf Holdings (OTC:CURLF) Navigates Reverse Stock Split and Strategic Market Uplisting

Curaleaf Holdings (OTC:CURLF) is an international provider of consumer cannabis products. The company operates in a highly competitive industry and is currently traded on the over-the-counter (OTC) market. It has a market capitalization of approximately $2.84 billion, positioning it as a major player in the global cannabis sector.

Curaleaf Holdings is set to undergo a 1-for-3 reverse stock split around June 5, 2026. A reverse stock split reduces the number of a company's outstanding shares. In this case, for every three shares an investor holds, they will receive one new share. The price per share is expected to increase proportionally.

This corporate action is a strategic step to prepare for a potential uplisting to a major U.S. stock exchange. As highlighted by PR Newswire, this move is made possible by potential changes in U.S. cannabis laws. Curaleaf also plans to move its corporate structure from Canada to Delaware to better align with U.S. markets.

The company's finances show a 6% revenue growth for the first quarter of 2026. This growth is supported by a strong 35% year-over-year increase in international revenues. While Curaleaf anticipates higher revenues in the next quarter, it also notes that it is currently facing pricing pressure on its products.

The stock is currently trading at $3.58, which is a 2.55% gain for the day. Over the past year, the stock has traded within a 52-week range of $0.72 and $5.05. This shows a significant amount of price movement and investor interest in the company's stock.

Published on: June 1, 2026